142 related articles for article (PubMed ID: 18270567)
1. HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivo.
Bulwin GC; Wälter S; Schlawinsky M; Heinemann T; Schulze A; Höhne W; Krause G; Kalka-Moll W; Fraser P; Volk HD; Löhler J; Milford EL; Utku N
PLoS One; 2008 Feb; 3(2):e1576. PubMed ID: 18270567
[TBL] [Abstract][Full Text] [Related]
2. TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
Frischer JM; Reindl M; Künz B; Berger T; Schmidt S; Milford EL; Knosp E; Lassmann H; Utku N
Mult Scler; 2014 Aug; 20(9):1171-81. PubMed ID: 24526664
[TBL] [Abstract][Full Text] [Related]
3. T-cell immune response cDNA 7 in allograft rejection and inflammation.
Utku N; Heinemann T; Milford EL
Curr Opin Investig Drugs; 2007 May; 8(5):401-10. PubMed ID: 17520869
[TBL] [Abstract][Full Text] [Related]
4. TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
Bulwin GC; Heinemann T; Bugge V; Winter M; Lohan A; Schlawinsky M; Schulze A; Wälter S; Sabat R; Schülein R; Wiesner B; Veh RW; Löhler J; Blumberg RS; Volk HD; Utku N
J Immunol; 2006 Nov; 177(10):6833-41. PubMed ID: 17082597
[TBL] [Abstract][Full Text] [Related]
5. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
[TBL] [Abstract][Full Text] [Related]
6. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation.
Ohyama H; Nishimura F; Meguro M; Takashiba S; Murayama Y; Matsushita S
Cytokine; 2002 Feb; 17(4):175-81. PubMed ID: 11991669
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide mimicking the HLA-DR beta 2-binding site for CD4 inhibits antigen-independent CD4+ T cell adhesion to B cells and CD4+ T cell activation.
Mazerolles F; Barbat C; Fischer A
Int Immunol; 1996 Feb; 8(2):267-74. PubMed ID: 8671612
[TBL] [Abstract][Full Text] [Related]
9. TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response.
Utku N; Boerner A; Tomschegg A; Bennai-Sanfourche F; Bulwin GC; Heinemann T; Loehler J; Blumberg RS; Volk HD
J Immunol; 2004 Aug; 173(4):2342-52. PubMed ID: 15294947
[TBL] [Abstract][Full Text] [Related]
10. ZAP-70 and p72syk are signaling response elements through MHC class II molecules.
Kanner SB; Grosmaire LS; Blake J; Schieven GL; Masewicz S; Odum N; Ledbetter JA
Tissue Antigens; 1995 Sep; 46(3 ( Pt 1)):145-54. PubMed ID: 8525473
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies.
Le Bas-Bernardet S; Coupel S; Chauveau A; Soulillou JP; Charreau B
Transplantation; 2004 Dec; 78(12):1729-39. PubMed ID: 15614145
[TBL] [Abstract][Full Text] [Related]
12. Characterization of IL-10-secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker.
Wakkach A; Augier S; Breittmayer JP; Blin-Wakkach C; Carle GF
J Immunol; 2008 May; 180(9):6054-63. PubMed ID: 18424726
[TBL] [Abstract][Full Text] [Related]
13. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
Damle NK; Leytze G; Klussman K; Ledbetter JA
Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
[TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.
Kuethe F; Braun RK; Foerster M; Schlenker Y; Sigusch HH; Kroegel C; Figulla HR
J Clin Immunol; 2006 Jan; 26(1):33-9. PubMed ID: 16418801
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
16. Umbilical cord blood dendritic cells are a rich source of soluble HLA-DR: synergistic effect of exosomes and dendritic cells on autologous or allogeneic T-Cell proliferation.
Gansuvd B; Hagihara M; Higuchi A; Ueda Y; Tazume K; Tsuchiya T; Munkhtuvshin N; Kato S; Hotta T
Hum Immunol; 2003 Apr; 64(4):427-39. PubMed ID: 12651069
[TBL] [Abstract][Full Text] [Related]
17. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein.
Utku N; Heinemann T; Tullius SG; Bulwin GC; Beinke S; Blumberg RS; Beato F; Randall J; Kojima R; Busconi L; Robertson ES; Schülein R; Volk HD; Milford EL; Gullans SR
Immunity; 1998 Oct; 9(4):509-18. PubMed ID: 9806637
[TBL] [Abstract][Full Text] [Related]
18. Signalling via MHC class II molecules modifies the composition of GEMs in APC.
Setterblad N; Becart S; Charron D; Mooney N
Scand J Immunol; 2001; 54(1-2):87-92. PubMed ID: 11439153
[TBL] [Abstract][Full Text] [Related]
19. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
[TBL] [Abstract][Full Text] [Related]
20. TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease.
Zhu F; Qiu T; Zhu S; Zhao K; Chen C; Qiao J; Pan B; Yan Z; Chen W; Liu Q; Wu Q; Cao J; Sang W; Zeng L; Sun H; Li Z; Xu K
Oncol Rep; 2020 Jul; 44(1):43-54. PubMed ID: 32319655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
